Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?

Background: Severe aortic valve stenosis (AS) is associated with pulmonary hypertension (PH) and has been shown to limit patient survival. Soluble suppression of tumorigenicity-2 (sST2) is a cardiovascular biomarker that has proven to be an important prognostic marker for survival in patients underg...

Descripción completa

Detalles Bibliográficos
Autores principales: Boxhammer, Elke, Mirna, Moritz, Bäz, Laura, Bacher, Nina, Topf, Albert, Sipos, Brigitte, Franz, Marcus, Kretzschmar, Daniel, Hoppe, Uta C., Lauten, Alexander, Lichtenauer, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954652/
https://www.ncbi.nlm.nih.gov/pubmed/35330140
http://dx.doi.org/10.3390/life12030389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954652/
https://www.ncbi.nlm.nih.gov/pubmed/35330140
http://dx.doi.org/10.3390/life12030389

Ejemplares similares